Feyza Catak-Bayram
Istanbul, 34142, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Identification of Dermatological Conditions Manageable in Primary Care: A Multidisciplinary Consensus Analysis.
Journal: Healthcare (Basel, Switzerland)
Published: May 07, 2026
A homozygous CTLA-4 variant causes CTLA-4 deficiency with severe immune dysregulation.
Journal: Journal of human immunity
Published: October 20, 2025
SPINK5 Variants Drive Clinical Variability in Netherton Syndrome Through Th2/Th17 Skewing and Influence Therapeutic Outcomes.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 01, 2025
Beyond the skin: immunological profiles and infectious complications in ALOX12B-associated autosomal recessive congenital ichthyosis.
Journal: Frontiers in immunology
Published: July 09, 2025
Abatacept restores dysregulated transcriptomic and proteomic profile in disorders of CTLA-4 insufficiency.
Journal: The Journal of allergy and clinical immunology
Published: June 04, 2025
Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease.
Journal: The Journal of allergy and clinical immunology
Published: September 22, 2024
Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey.
Journal: Journal of clinical immunology
Published: July 08, 2024
Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.
Journal: Journal of clinical immunology
Published: November 06, 2023
Corrigendum to "Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients" [Clinical Immunology 255 (2023) 109757].
Journal: Clinical immunology (Orlando, Fla.)
Published: October 16, 2023
Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients.
Journal: Clinical immunology (Orlando, Fla.)
Published: May 11, 2023
Tau immunotherapy in Alzheimer's disease and progressive supranuclear palsy.
Journal: International immunopharmacology
Published: August 11, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026